Literature DB >> 17599417

Approaches to estimate the population-based incidence of community acquired pneumonia.

Maike Schnoor1, Jens Hedicke, Klaus Dalhoff, Heiner Raspe, Torsten Schäfer.   

Abstract

OBJECTIVES: In Germany the estimation of a population based annual incidence of community acquired pneumonia (CAP) in adults has been referred to the denominator problem. To estimate a population based annual incidence of CAP in an urban German area we compared the incidence estimated on four different approaches.
METHODS: We estimated the annual incidence on the basis of the covered population of sentinel practices from Luebeck participating in the German competence network CAPNETZ. We estimated the incidence on the basis of a population based survey, on the basis of the mortality and lethality in Luebeck, and on the basis of data of the regional Association of Statutory Health Insurance Physicians ("Kassenärztliche Vereinigung (KV) Schleswig-Holstein").
RESULTS: The annual incidence of CAP in Luebeck was 3.7/1000 inhabitants (95% confidence interval (CI) 2.4-5.5), 6.0/1000 inhabitants, 8.7/1000 inhabitants (95% CI 8.2-9.1), or 10.1/1000 inhabitants (95% CI 9.6-10.5) depending on the approach of estimation. According to this, in Germany we would expect 400,000-680,000 new CAP cases per year.
CONCLUSIONS: The true incidence of CAP in Luebeck might range between 3.7 and 10 per 1000 inhabitants. Comparisons with the rates in the literature are difficult due to the differences in the applied methods.

Entities:  

Mesh:

Year:  2007        PMID: 17599417     DOI: 10.1016/j.jinf.2007.04.355

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  28 in total

1.  [Prevention in the elderly: position paper on pneumococcal vaccinations. Results of an expert workshop on 15 November 2013 in Cologne, Germany].

Authors:  G Fätkenheuer; A Kwetkat; M W Pletz; J Schelling; R-J Schulz; M van der Linden; T Welte
Journal:  Z Gerontol Geriatr       Date:  2014-06       Impact factor: 1.281

2.  Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.

Authors:  Alexander Kuhlmann; J-Matthias Graf von der Schulenburg
Journal:  Eur J Health Econ       Date:  2016-02-23

3.  [Community-acquired pneumonia: a disease of the elderly].

Authors:  T Welte
Journal:  Z Gerontol Geriatr       Date:  2011-08       Impact factor: 1.281

4.  [Incidence rate of community acquired pneumonia in a population cohort registered in BIFAP].

Authors:  Ana Chacón García; Ana Ruigómez; Luis Alberto García Rodríguez
Journal:  Aten Primaria       Date:  2010-09-15       Impact factor: 1.137

Review 5.  Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.

Authors:  T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

Review 6.  Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.

Authors:  Katelijne van de Vooren; Silvy Duranti; Alessandro Curto; Livio Garattini
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

7.  Pneumonia in the Noninstitutionalized Older Population.

Authors:  Lutz P Breitling; Kai-Uwe Saum; Ben Schöttker; Bernd Holleczek; Felix J Herth; Hermann Brenner
Journal:  Dtsch Arztebl Int       Date:  2016-09-16       Impact factor: 5.594

Review 8.  Is Vitamin C Beneficial to Patients with CAP?

Authors:  Yin Li; Guoping Li
Journal:  Curr Infect Dis Rep       Date:  2016-08       Impact factor: 3.725

Review 9.  [Community-acquired pneumonia].

Authors:  T Welte
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

10.  Distribution of the atypical pathogens of community-acquired pneumonia to disease severity.

Authors:  Cheng Gong; Tiegang Zhang; Ming Luo; Aihua Li; Mei Dong; Maozhong Li; Yiting Wang; Fang Huang
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.